Intelligence Platform

Patents

Browse 20 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9937157

Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inh

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9889152

Multiple PPI dosage form

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9889125

Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopi

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9255063

Colchicine solid-state forms; methods of making; and methods of use thereof

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9248119

Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inh

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9238029

Multiple PPI dosage form

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9233103

Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopi

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9107912

Methods for concomitant treatment of theophylline and febuxostat

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8841333

Methods for treating nephrolithiasis

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785491

Pharmaceutical compositions and methods for treating age-related macular degeneration with

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8519002

Colchicine solid complex; methods of making; and methods of use thereof

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8497290

Thiocolchicine derivatives, method of making and methods of use thereof

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8461187

Multiple PPI dosage form

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8445541

Methods for concomitant administration of colchicine and a second active agent

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8440721

Methods for concomitant administration of colchicine and a second active agent

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8440722

Methods for concomitant administration of colchicine and a second active agent

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8415396

Colchine compositions and methods

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8415395

Colchicine compositions and methods

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8372872

Methods for concomitant treatment of theophylline and febuxostat

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173158

Methods of treating gastrointestinal disorders independent of the intake of food

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted